{"id":"https://openalex.org/W2069459596","doi":"https://doi.org/10.1111/j.1463-1326.2004.00383.x","title":"Improvement of glucose tolerance in Zucker diabetic fatty rats by long\u2010term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone","display_name":"Improvement of glucose tolerance in Zucker diabetic fatty rats by long\u2010term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone","publication_year":2004,"publication_date":"2004-11-15","ids":{"openalex":"https://openalex.org/W2069459596","doi":"https://doi.org/10.1111/j.1463-1326.2004.00383.x","mag":"2069459596","pmid":"https://pubmed.ncbi.nlm.nih.gov/15715890"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2004.00383.x","doi":"https://doi.org/10.1111/j.1463-1326.2004.00383.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2004.00383.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023044490","display_name":"Edward Taynton Wargent","orcid":"https://orcid.org/0000-0002-8545-2430","observed_orcids":["https://orcid.org/0000-0002-8545-2430"]},"institutions":[{"id":"https://openalex.org/I92864154","display_name":"University of Buckingham","ror":"https://ror.org/03kd28f18","country_code":"GB","type":"education","lineage":["https://openalex.org/I92864154"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E. Wargent","raw_affiliation_strings":["Clore Laboratory, University of Buckingham, Buckingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clore Laboratory, University of Buckingham, Buckingham, UK","institution_ids":["https://openalex.org/I92864154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040763004","display_name":"Claire Joanne Stocker","orcid":"https://orcid.org/0000-0002-0178-7349","observed_orcids":["https://orcid.org/0000-0002-0178-7349"]},"institutions":[{"id":"https://openalex.org/I92864154","display_name":"University of Buckingham","ror":"https://ror.org/03kd28f18","country_code":"GB","type":"education","lineage":["https://openalex.org/I92864154"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Stocker","raw_affiliation_strings":["Clore Laboratory, University of Buckingham, Buckingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clore Laboratory, University of Buckingham, Buckingham, UK","institution_ids":["https://openalex.org/I92864154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041225542","display_name":"Petra Augstein","orcid":"https://orcid.org/0000-0001-9859-8263","observed_orcids":["https://orcid.org/0000-0001-9859-8263"]},"institutions":[{"id":"https://openalex.org/I4210145262","display_name":"Institute for Diabetes Gerhardt Katsch","ror":"https://ror.org/05d854h51","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210145262"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P. Augstein","raw_affiliation_strings":["Institut fu\u0308r Diabetes \u201cGerhardt Katsch\u201d, Karlsburg, Germany","Institut f\u00fcr Diabetes \u201cGerhardt Katsch\u201d, Karlsburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut fu\u0308r Diabetes \u201cGerhardt Katsch\u201d, Karlsburg, Germany","institution_ids":["https://openalex.org/I4210145262"]},{"raw_affiliation_string":"Institut f\u00fcr Diabetes \u201cGerhardt Katsch\u201d, Karlsburg, Germany","institution_ids":["https://openalex.org/I4210145262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047097813","display_name":"Peter Heinke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145262","display_name":"Institute for Diabetes Gerhardt Katsch","ror":"https://ror.org/05d854h51","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210145262"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P. Heinke","raw_affiliation_strings":["Institut fu\u0308r Diabetes \u201cGerhardt Katsch\u201d, Karlsburg, Germany","Institut f\u00fcr Diabetes \u201cGerhardt Katsch\u201d, Karlsburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut fu\u0308r Diabetes \u201cGerhardt Katsch\u201d, Karlsburg, Germany","institution_ids":["https://openalex.org/I4210145262"]},{"raw_affiliation_string":"Institut f\u00fcr Diabetes \u201cGerhardt Katsch\u201d, Karlsburg, Germany","institution_ids":["https://openalex.org/I4210145262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027238188","display_name":"Antje Meyer","orcid":"https://orcid.org/0000-0003-1675-4512","observed_orcids":["https://orcid.org/0000-0003-1675-4512"]},"institutions":[{"id":"https://openalex.org/I4210144058","display_name":"Probiodrug (Germany)","ror":"https://ror.org/03p4y9t51","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210144058"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Meyer","raw_affiliation_strings":["Probiodrug AG, Halle (Saale), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probiodrug AG, Halle (Saale), Germany","institution_ids":["https://openalex.org/I4210144058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113580795","display_name":"T. Hoffmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144058","display_name":"Probiodrug (Germany)","ror":"https://ror.org/03p4y9t51","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210144058"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"T. Hoffmann","raw_affiliation_strings":["Probiodrug AG, Halle (Saale), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probiodrug AG, Halle (Saale), Germany","institution_ids":["https://openalex.org/I4210144058"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Subramanian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I92864154","display_name":"University of Buckingham","ror":"https://ror.org/03kd28f18","country_code":"GB","type":"education","lineage":["https://openalex.org/I92864154"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Subramanian","raw_affiliation_strings":["Clore Laboratory, University of Buckingham, Buckingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clore Laboratory, University of Buckingham, Buckingham, UK","institution_ids":["https://openalex.org/I92864154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109958883","display_name":"Matthew V. Sennitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I92864154","display_name":"University of Buckingham","ror":"https://ror.org/03kd28f18","country_code":"GB","type":"education","lineage":["https://openalex.org/I92864154"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. V. Sennitt","raw_affiliation_strings":["Clore Laboratory, University of Buckingham, Buckingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clore Laboratory, University of Buckingham, Buckingham, UK","institution_ids":["https://openalex.org/I92864154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001127178","display_name":"Hans\u2010Ulrich Demuth","orcid":"https://orcid.org/0000-0002-5276-0007","observed_orcids":["https://orcid.org/0000-0002-5276-0007"]},"institutions":[{"id":"https://openalex.org/I4210144058","display_name":"Probiodrug (Germany)","ror":"https://ror.org/03p4y9t51","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210144058"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H.\u2010U. Demuth","raw_affiliation_strings":["Probiodrug AG, Halle (Saale), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probiodrug AG, Halle (Saale), Germany","institution_ids":["https://openalex.org/I4210144058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113565684","display_name":"Jonathan R. S. Arch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I92864154","display_name":"University of Buckingham","ror":"https://ror.org/03kd28f18","country_code":"GB","type":"education","lineage":["https://openalex.org/I92864154"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"J. R. S. Arch","raw_affiliation_strings":["Clore Laboratory, University of Buckingham, Buckingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clore Laboratory, University of Buckingham, Buckingham, UK","institution_ids":["https://openalex.org/I92864154"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110226856","display_name":"Michael Anthony Cawthorne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I92864154","display_name":"University of Buckingham","ror":"https://ror.org/03kd28f18","country_code":"GB","type":"education","lineage":["https://openalex.org/I92864154"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. A. Cawthorne","raw_affiliation_strings":["Clore Laboratory, University of Buckingham, Buckingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clore Laboratory, University of Buckingham, Buckingham, UK","institution_ids":["https://openalex.org/I92864154"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5113565684"],"corresponding_institution_ids":["https://openalex.org/I92864154"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":1.2906,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.81134704,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"7","issue":"2","first_page":"170","last_page":"181"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dipeptidyl-peptidase-inhibitors","display_name":"dipeptidyl peptidase inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.9919999837875366},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.8460000157356262},{"id":"https://openalex.org/keywords/zucker-diabetic-fatty-rats","display_name":"Zucker diabetic fatty rats","score":0.8569999933242798},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8569999933242798},{"id":"https://openalex.org/keywords/prediabetes","display_name":"prediabetes","score":0.8019999861717224},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.8270000219345093},{"id":"https://openalex.org/keywords/islet-histology","display_name":"islet histology","score":0.796999990940094},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5659999847412109},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.5789999961853027},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.5529999732971191},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.39800000190734863},{"id":"https://openalex.org/keywords/pancreatic-islets","display_name":"pancreatic islets","score":0.4569999873638153},{"id":"https://openalex.org/keywords/age-at-treatment-initiation","display_name":"age at treatment initiation","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.9126265645027161},{"id":"https://openalex.org/C2778763485","wikidata":"https://www.wikidata.org/wiki/Q419770","display_name":"Dipeptidyl peptidase-4 inhibitor","level":4,"score":0.6740305423736572},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.6505383849143982},{"id":"https://openalex.org/C2781469919","wikidata":"https://www.wikidata.org/wiki/Q5279728","display_name":"Dipeptidyl peptidase","level":3,"score":0.5693913698196411},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.539508044719696},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5158409476280212},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47808218002319336},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.4675276279449463},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.41005268692970276},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3907119333744049},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38690686225891113},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37431997060775757},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2062218189239502},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.06290134787559509},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004326","descriptor_name":"Drinking","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004435","descriptor_name":"Eating","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D005951","descriptor_name":"Glucose Tolerance Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007515","descriptor_name":"Islets of Langerhans","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010421","descriptor_name":"Pentanoic Acids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010421","descriptor_name":"Pentanoic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011924","descriptor_name":"Rats, Zucker","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053778","descriptor_name":"Thiazolidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1463-1326.2004.00383.x","doi":"https://doi.org/10.1111/j.1463-1326.2004.00383.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2004.00383.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:15715890","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15715890","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W2004507897","https://openalex.org/W2030347165","https://openalex.org/W2044041315","https://openalex.org/W2056726092","https://openalex.org/W2068361325","https://openalex.org/W2068364170","https://openalex.org/W2076880341","https://openalex.org/W2091026280","https://openalex.org/W2091226888","https://openalex.org/W2096119759","https://openalex.org/W2096872771","https://openalex.org/W2100400393","https://openalex.org/W2121508402","https://openalex.org/W2131669718","https://openalex.org/W2135173562","https://openalex.org/W2141264129","https://openalex.org/W2145140318","https://openalex.org/W2147297030","https://openalex.org/W2154615287","https://openalex.org/W2162768091","https://openalex.org/W2319030457","https://openalex.org/W2327071073","https://openalex.org/W4244634071"],"related_works":["https://openalex.org/W2132948641","https://openalex.org/W2100400393","https://openalex.org/W2141264129","https://openalex.org/W2171024875","https://openalex.org/W4241457676","https://openalex.org/W2088977563","https://openalex.org/W2127588320","https://openalex.org/W2070271329","https://openalex.org/W1990474694","https://openalex.org/W2001739257"],"abstract_inverted_index":{"AIM:":[0],"The":[1,119,138,302],"aim":[2],"of":[3,11,31,49,62,79,87,94,104,117,145,182,189,199,242,258,304,314,355],"this":[4],"study":[5],"was":[6,70,83,98,140,162,333],"to":[7,72,85,106,312,319],"investigate":[8],"the":[9,15,47,60,77,108,127,136,143,186,232,235],"effect":[10],"long-term":[12],"treatment":[13,42,177,190,192,207,252,343],"with":[14,23,57,213],"dipeptidyl":[16],"peptidase":[17],"inhibitor":[18],"P32/98":[19,58,82,113,166,201,243,260,270,287,305,321],"and":[20,29,133,152,173,218,221,231,298,308,316],"its":[21],"combination":[22],"rosiglitazone":[24,214,272],"on":[25,283,306],"blood":[26,204,227],"glucose":[27,154,168,205,236,246,266,293,307],"control":[28],"islet":[30,160,284],"Langerhans":[32],"histology":[33,161],"in":[34,135,248,264,292,295,317,339],"male":[35],"Zucker":[36],"diabetic":[37,299],"fatty":[38],"(ZDF)":[39],"rats,":[40],"when":[41,176,191,206,342],"begins":[43],"before":[44],"or":[45,65,196,327,348,351],"after":[46,170,185,222],"development":[48],"overt":[50],"diabetes.":[51],"METHODS:":[52],"ZDF":[53,300,340],"rats":[54,90,109,128,341],"were":[55,111,121,129,156,310],"treated":[56],"from":[59,76,91,101,114],"age":[61,78,105,144],"9,":[63,346],"12":[64,195,210,347],"15":[66,197,349],"weeks.":[67,81,147,211],"Rosiglitazone":[68,96],"maleate":[69,97],"given":[71,84,100,112,122],"a":[73,289],"separate":[74],"group":[75],"13":[80,352],"all":[86],"these":[88],"rosiglitazone-treated":[89,249],"16":[92,102],"weeks":[93,103,116,131,181,198,257,354],"age.":[95,118,200,356],"also":[99,184],"half":[107],"that":[110],"9":[115,180,256],"compounds":[120],"by":[123],"oral":[124,153],"gavage":[125],"until":[126],"14":[130],"old":[132],"then":[134],"diet.":[137],"experiment":[139],"terminated":[141],"at":[142,158,179,194,209,255,336,345],"20-21":[146],"Blood":[148],"glucose,":[149,228],"plasma":[150],"insulin":[151,262,275,309],"tolerance":[155,169,237,247,267,294],"measured":[157],"intervals;":[159],"assessed":[163],"terminally.":[164],"RESULTS:":[165],"improved":[167,245],"both":[171,296],"single":[172,240],"multiple":[174],"doses":[175],"started":[178],"age,":[183,259],"third":[187],"week":[188],"began":[193,208,344],"reduced":[202,225],"daytime":[203,226],"Treatment":[212],"increased":[215],"food":[216,325],"intake":[217,230,326],"body":[219,328],"weight,":[220],"2":[223],"weeks,":[224],"water":[229],"area":[233],"under":[234],"curve.":[238],"A":[239],"dose":[241],"markedly":[244],"rats.":[250,301],"When":[251],"had":[253],"begun":[254],"stimulated":[261],"secretion":[263],"some":[265],"tests.":[268],"Neither":[269],"nor":[271,277],"affected":[273],"pancreatic":[274],"content,":[276],"did":[278,322],"they":[279],"have":[280],"clear":[281],"effects":[282,303],"histology.":[285],"CONCLUSION:":[286],"elicited":[288],"sustained":[290],"improvement":[291],"prediabetic":[297],"similar":[311],"those":[313],"rosiglitazone,":[315,320],"contrast":[318],"not":[323],"increase":[324],"weight.":[329],"However,":[330],"neither":[331],"compound":[332],"especially":[334],"effective":[335],"improving":[337],"diabetes":[338],"(P32/98)":[350],"(rosiglitazone)":[353]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}